About PathAI
PathAI is a Healthcare company based in Boston (United States) founded in 2016 by Andrew H Beck. PathAI has raised $254.94 million across 5 funding rounds from investors including Kaiser Permanente, LabCorp and General Atlantic. The company has 573 employees. PathAI has completed 1 acquisition, including Poplar Healthcare. Its chief executive, as recorded, is Andrew H Beck. Its website pathai.com draws about 88 thousand monthly visits. Its focus areas include HealthTech, Healthcare IT, Provider and Clinical Operations. Its legal entity is PATHAI, INC. Its competitors include Viz.ai, Deepcell and Pictor Labs; 3 of its 3 listed competitors have raised funding.
Company details
Provider of AI-based solutions for clinical diagnosis of cancer and other diseases. The company is applying deep learning techniques to massive aggregated sets of pathology data to build models that can automatically detect and diagnose medical conditions.
- Headquarters Boston, United States
- Employees 573
- Founders Andrew H Beck
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website pathai.com
- Social LinkedIn X
- Legal Name Pathai, Inc.
- Total Equity Funding$254.94M (USD)
in 5 rounds
- Latest Funding Round$165M (USD), Series C
May 2021
- InvestorsKaiser Permanente
& 15 more
- Employee Count573
- Investments & Acquisitions
Funding Insights of PathAI
PathAI has successfully raised a total of $254.94M across 5 strategic funding rounds. The most recent funding activity was a Series C round of $165 million completed in May 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $254.94M
- Total Rounds 5
- Last Round Series C — $165M
- First Round $14.94M
(Oct 2017)
- Investors Count 16
All 5 funding rounds of PathAI with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May 2021 | $165M | Series C | – | Kaiser Permanente, Tiger Global Management | |
| Nov 2019 | $15M | Series B | – | Bristol-Myers Squibb, Merck Global Health Innovation Fund | – |
| Jul 2019 | Series B | – | LabCorp | – | |
| Apr 2019 | $60M | Series B | – | General Catalyst, General Atlantic | |
| Oct 2017 | $14.94M | Series A | – | General Catalyst |
16 investors in total: 16 institutional.
Investors in PathAI
PathAI has secured backing from 16 investors, including institutional and venture fund investors. Prominent investors backing the company include Kaiser Permanente, LabCorp and General Atlantic.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Private equity fund focused on global markets | 1980 | generalatlantic.com | New York, United States | |
Venture and private equity investments are managed with global diversification. | tigerglobal.com | New York, United States | ||
Biospring is engaged in partnering with pharma services businesses. | biospring.com | New York, United States | ||
US focused venture capital firm | polarispartners.com | Boston, United States | ||
Investment and transformation services for entrepreneurs in technology and finance sectors. | generalcatalyst.com | |||
Corporate-backed venture capital is focused on the life science sector. | merckghifund.com | Kenilworth, United States | ||
Seed and early-stage investments are made across US and India. | refactor.com | Burlingame, United States | ||
Venture capital firm investing in technology, life sciences, and related sectors. | 8vc.com | |||
Early-stage investments are made in frontier science ventures. | kdtvc.com | Black Mountain, United States | ||
Private equity and hedge fund focused on consumer, business services, financial, healthcare, and multiple sectors | d1capital.com | New York, United States |
Investor details for PathAI
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of PathAI
96 people are tracked at PathAI (34 in leadership, 62 in team); the tracked headcount is 573.
| Name | Role | Group |
|---|---|---|
Andrew H Beck | Co-Founder & CEO | Leadership |
Mike Montalto | Chief Scientific Officer | Leadership |
Katy Wack | VP, Clinical Development and Regulatory Affairs | Leadership |
Kyle de la Cena | Associate Director, Clinical Operations | Leadership |
Bik Yonjan | Senior Director of Product Development | Leadership |
Benjamin Glass | Vice President Of Product And Translational Research | Leadership |
Manasa Chandra | Director, Biopharma Partnerships | Leadership |
Jim Sweeney | Diagnostics President | Leadership |
Eric Walk | Chief Medical Officer | Leadership |
Liz Storti | Chief People Officer | Leadership |
Cristin Taylor | Director, Clinical Science | Leadership |
Laura Heo | Head Of Talent Acquisition | Leadership |
Debora Greenblatt | Chief Commercial Officer, Diagnostics | Leadership |
Syed Ashar Javed | Associate Director - Machine Learning | Leadership |
Brandon Eldredge | CFO | Leadership |
Lety Booth | Senior Director, Quality and Compliance | Leadership |
Nick Brown | Chief Growth Officer | Leadership |
Carlee Hemphill | Director, Pathology And Biomarker Strategy | Leadership |
Elizabeth Storti | Chief People Officer | Leadership |
Bahar Rahsepar | Associate Director Of AI Products | Leadership |
76 more people are available in the full profile.
Complete people profiles for PathAI
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by PathAI
PathAI has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Poplar Healthcare.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Pathology laboratory services are operated across a chain of facilities. | poplarhealthcare.com | Memphis, United States | 1995 | Jul 2021 | •••• |
Complete acquisition details for PathAI
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of PathAI
4 dated milestones of PathAI across 5 years, from founding to its latest funding, stage changes and deals.
- Founded PathAI is founded.
- Funding First funding round of $14.9M.
- Funding Latest funding round, Series C, of $165.0M.
- Acquisition Acquires Poplar Healthcare.
Competitors of PathAI
PathAI has 3 listed competitors in our database, 3 of them funded. They include Viz.ai, Deepcell and Pictor Labs.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| viz.ai | 2016 | San Francisco, United States | $251.99M | 206 | AI and cloud-powered software for stroke care coordination is developed. | |
| deepcell.com | 2015 | Mountain View, United States | $122.99M | 94 | AI-powered single cell classification and isolation technology for clinical research | |
| pictorlabs.ai | 2019 | Los Angeles, United States | $48.83M | AI-based tools for pathological image analysis are provided to labs. |
Detailed competitors of PathAI
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of PathAI
The website of PathAI (pathai.com) receives about 87.5K visits a month.
- Monthly visits87.5K
▲ 8.8% vs previous month
Websites whose visitors overlap most with PathAI. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
jobs.sciencecareers.org | jobs.sciencecareers.org | 100% | #274,063 | – | |
| nature.com | 85% | 33.6M | #1,922 | View details | |
| arxiv.org | 65% | 24.2M | #2,532 | View details | |
| ionq.com | 60% | 321.8K | #190,698 | View details | |
| esri.com | 60% | 2.2M | #26,968 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 6 similar websites and full traffic analytics for PathAI
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 6 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Clinical IT & Data Platforms
3 companies that operate in the same segment as PathAI (Clinical IT & Data Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Employee health benefits are facilitated via a cloud-based platform. | 2007 | Plymouth Meeting, Pennsylvania, United States | USD 228.3 M | |||
Healthcare appointments are booked online via Zocdoc's platform. | 2007 | New York, New York, United States | USD 425.97 M | USD 4.66 M | 1,365 | |
Virtual physical therapy and digital pain care solutions are provided. | 2015 | San Francisco, California, United States | USD 854.44 M | 1,746 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Pathai
Complete news archive for PathAI
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about PathAI
PathAI was founded in 2016 and raised its 1st funding round 1 year after it was founded.
PathAI is headquartered in Boston, United States. It is registered at Boston, Massachusetts, United States.
Andrew H Beck is the CEO of PathAI, as recorded in our data. They have also founded this company.
PathAI is a funded company, having raised a total of $254.94M across 5 funding rounds to date. The company's 1st funding round was a Series A of $14.94M, raised on Oct 2017.
PathAI has 573 employees.
Provider of AI-based solutions for clinical diagnosis of cancer and other diseases. The company is applying deep learning techniques to massive aggregated sets of pathology data to build models that can automatically detect and diagnose medical conditions.
PathAI's top competitors include Pictor Labs, Viz.ai and Deepcell.
PathAI has made 1 acquisition, including Poplar Healthcare.
PathAI has 16 investors. Key investors include Kaiser Permanente, LabCorp, General Atlantic, Bristol-Myers Squibb, and Tiger Global.
PathAI operates through Pathai, Inc..